Vaccinex, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (6)

Latest Posts

About This Stock More About This Stock
Vaccinex Provides Update Of Potentially Pivotal SIGNAL Clinical Trial In Huntington’s Disease
Article By: TalkMarkets Newswire
Tuesday, July 7, 2020 8:34 AM EST
Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.
In this article: VCNX Also: ARDS, ALNY, UROV, UMRX
Read

Latest Tweets for $VCNX

No tweets yet!